Larimar Therapeutics Statistics
Total Valuation
LRMR has a market cap or net worth of $594.63 million. The enterprise value is $371.34 million.
Market Cap | 594.63M |
Enterprise Value | 371.34M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
Earnings Date | Aug 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LRMR has 63.80 million shares outstanding. The number of shares has increased by 22.00% in one year.
Shares Outstanding | 63.80M |
Shares Change (YoY) | +22.00% |
Shares Change (QoQ) | +21.97% |
Owned by Insiders (%) | 1.45% |
Owned by Institutions (%) | 105.44% |
Float | 31.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.58 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.99, with a Debt / Equity ratio of 0.02.
Current Ratio | 17.99 |
Quick Ratio | n/a |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.70% and return on invested capital (ROIC) is -21.53%.
Return on Equity (ROE) | -35.70% |
Return on Assets (ROA) | -32.20% |
Return on Capital (ROIC) | -21.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.07M |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +192.16% in the last 52 weeks. The beta is 0.78, so LRMR's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | +192.16% |
50-Day Moving Average | 8.37 |
200-Day Moving Average | 6.47 |
Relative Strength Index (RSI) | 54.41 |
Average Volume (20 Days) | 806,243 |
Short Selling Information
The latest short interest is 2.88 million, so 4.52% of the outstanding shares have been sold short.
Short Interest | 2.88M |
Short Previous Month | 3.27M |
Short % of Shares Out | 4.52% |
Short % of Float | 9.07% |
Short Ratio (days to cover) | 4.08 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -50.86M |
Pretax Income | -45.08M |
Net Income | -45.08M |
EBITDA | -44.87M |
EBIT | -45.08M |
Earnings Per Share (EPS) | -$0.96 |
Balance Sheet
The company has $228.64 million in cash and $5.35 million in debt, giving a net cash position of $223.29 million or $3.50 per share.
Cash & Cash Equivalents | 228.64M |
Total Debt | 5.35M |
Net Cash | 223.29M |
Net Cash Per Share | $3.50 |
Equity (Book Value) | 230.84M |
Book Value Per Share | 3.62 |
Working Capital | 218.11M |
Cash Flow
In the last 12 months, operating cash flow was -$36.32 million and capital expenditures -$164,000, giving a free cash flow of -$36.48 million.
Operating Cash Flow | -36.32M |
Capital Expenditures | -164,000 |
Free Cash Flow | -36.48M |
FCF Per Share | -$0.68 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LRMR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.00% |
Shareholder Yield | -22.00% |
Earnings Yield | -7.58% |
FCF Yield | -6.14% |
Analyst Forecast
The average price target for LRMR is $21.33, which is 128.86% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.33 |
Price Target Difference | 128.86% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 28.72% |
Stock Splits
The last stock split was on May 29, 2020. It was a reverse split with a ratio of 1:12.
Last Split Date | May 29, 2020 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |